文献速递介入技术与安全CT

机器人辅助CT引导介入的现状与前景

Robot-assisted CT-guided interventions: Where are we now and where are we going?
PubMed 文献 · Eur Radiol · 2026-09-05

本文为叙述性综述,依据SANRA原则检索PubMed、Scopus及临床试验注册库,纳入机器人辅助CT引导经皮介入的临床前、可行性及对比研究,并用IDEAL框架分析。结果显示机器人辅助可提高穿刺精准度、减少调针次数和术者辐射,临床证据集中在肝、肺、肾及肌骨系统,但多数研究处于IDEAL 1-2b阶段。结论认为该技术属精准赋能手段,尚未成为标准治疗,广泛推广需更强对比研究和经济学评价。

要点

  • 复杂长轴、斜行、平面外穿刺路径可优先考虑机器人辅助以提高精准度。
  • 机器人辅助常可减少术者辐射剂量,但手术时间和患者剂量影响不一致。
  • 现有临床证据集中在肝、肺、肾及肌骨系统,且多为早期阶段研究。

核心结论

  • 机器人辅助CT引导介入属于精准赋能技术,但尚未成为标准治疗。
  • 现有证据支持在技术复杂操作中选择性使用机器人辅助。
  • 更广泛应用取决于稳健的对比研究、经济学评价和结构化实施框架。

研究设计与样本

  • 叙述性综述,遵循高质量叙述性综述建议并参考SANRA原则。
  • 检索范围包括PubMed、Scopus和临床试验注册库中评估机器人CT引导经皮介入的研究。
  • 纳入临床前研究、可行性研究和对比性临床研究,并用IDEAL框架进行定性解读和分期。

关键影像表现/征象

  • 临床前研究一致显示机器人辅助较徒手技术在目标精准度上提高且调针次数减少。
  • 现有临床证据集中在肝、肺、肾及肌骨系统,尤其是长轴、斜行及平面外穿刺路径。

诊断标准与关键数值

  • 多数已发表研究对应IDEAL分期1至2b阶段,3期随机评估正在出现。
  • 长期随访数据和注册登记数据仍然有限。
  • 操作者辐射暴露常可减少,而手术时间和患者剂量效应在不同研究中结果不一。

临床应用与阅片要点

  • 在肝、肺、肾及肌骨系统的复杂活检和消融操作中可考虑机器人辅助以提高穿刺精准度。
  • 日常阅片报告中暂不涉及机器人辅助的影像征象判读,但需关注穿刺路径规划对图像引导的要求。
  • 阅片时应警惕机器人辅助操作中可能出现的与计划路径相关的并发症,尤其是长轴和斜行路径。

局限性

  • 多数研究处于IDEAL 1-2b阶段,证据成熟度仍偏低。
  • 长期随访数据和注册登记数据不足。
  • 手术时间和患者剂量效应在不同研究中不一致,影响常规推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Computed tomography (CT)-guided interventions are central to interventional radiology (IR) but remain highly operator-dependent. Robotic assistance has been proposed to improve needle accuracy, reproducibility and radiation safety. While robotics are well established in surgery, their role in CT-guided IR remains evolving. This review synthesises current evidence, maps robotic CT-guided interventions onto the IDEAL framework for procedural innovation, and evaluates where these systems provide measurable clinical value.

MATERIALS AND METHODS: A narrative review was conducted according to established recommendations for high-quality narrative reviews and informed by SANRA principles. PubMed, Scopus and clinical trial registries were searched for studies evaluating robotic CT-guided percutaneous interventions. Evidence from preclinical, feasibility and comparative clinical studies was synthesised qualitatively and interpreted using the IDEAL framework.

RESULTS: Preclinical studies consistently demonstrate improved targeting accuracy and fewer needle adjustments compared with freehand techniques. Clinical studies and systematic reviews support feasibility and safety across biopsy and ablation applications, with current clinical evidence concentrated in the liver, lung, kidney, and musculoskeletal system, particularly for long, oblique, and out-of-plane trajectories. Operator radiation exposure is frequently reduced, while procedure time and patient dose effects are variable. Most published studies correspond to IDEAL stages 1-2b, with emerging Stage 3 randomised evaluation; long-term and registry data remain limited.

CONCLUSION: Robot-assisted CT-guided interventions represent precision-enabling technologies but are not yet standard of care. Current evidence supports selective use in technically complex procedures. Wider adoption will depend on robust comparative studies, economic evaluation and structured implementation frameworks.

KEY POINTS: Question What evidence supports robot-assisted CT-guided interventions in IR, and in which procedures do robotic systems provide clinical benefit? Findings Current clinical evidence is concentrated in liver, lung, kidney, and musculoskeletal interventions, demonstrating improved targeting precision and reduced needle adjustments and operator radiation exposure. Clinical relevance Robot-assisted CT-guided interventions may improve procedural precision and reduce radiation exposure in complex interventions, but wider adoption depends on stronger comparative evidence demonstrating meaningful clinical benefit, workflow efficiency, and cost-effectiveness.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. O'Dwyer, Temperley, O'Sullivan, et al. Robot-assisted CT-guided interventions: Where are we now and where are we going? Eur Radiol. 2026. PMID: 42701129. doi:10.1007/s00330-026-12850-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。